We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
ScripsAmerica Inc (CE) | USOTC:SCRCQ | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.000001 | 0.00 | 01:00:00 |
Will Report Preliminary Fiscal 2014 Revenues of over $31 Million and Profitable Second Half of Year
Now Projecting First Quarter 2015 Net Income of over $400,000 on Revenues of more than $9.5 Million
ScripsAmerica, Inc. (OTCBB: SCRC), a leading provider of a range of specialty prescription and over the counter pharmaceuticals and medical supplies, today provided the investment community highlights of comments it will be making at the Wall Street Analyst Forum’s 25th Annual Institutional Investor Conference about the Company's significantly improved financial results, outstanding growth of the specialty pharmacy business and rapid emergence of new revenue streams from diabetic medical supplies, PIMD International, Inc. and physician dispensing programs. This conference will be held at the University Club in New York, NY on Thursday, March 19, 2015.
Mr. Schneiderman said, "Our goal is to generate value for our shareholders and the outstanding financial performance achieved in fiscal 2014, especially over the second half of the year, has created tremendous momentum heading into 2015, with current projections of a profitable first quarter of 2015. We have put in place a strategy that capitalizes on unique market niches where ScripsAmerica has a competitive advantage, and have built the infrastructure and management team that can effectively execute a plan to grow in these markets. While there will always be headwinds, because of our increasing financial strength and diverse product offerings, we are confident that ScripsAmerica will generate attractive growth in fiscal 2015 with significant improvement to the bottom line."
A live webcast of the Company’s presentation at the Wall Street Analyst Forum’s Institutional Investor Conference can be accessed from ScripsAmerica’s website at: www.ScripsAmerica.com.
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com.
Gregory FCAJoe Hassett, 610-228-2110joeh@gregoryfca.com
1 Year ScripsAmerica (CE) Chart |
1 Month ScripsAmerica (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions